1124P Phase Ib study to evaluate the safety of selinexor (SEL) in combination with pembrolizumab (PEM) in patients with advanced malignancies- the: The melanoma experience
Year: 2020
Type: article
Source: Annals of Oncology
Authors: I.C. Glitza, S. Patel, A. Zarifa, C.H. Leung, H. Lin, L. McQuinn, J. Gong, B. Yilmaz, J. Chambers, S. Sulovic, I. John, T. Hennegan, S. Fu, A.M. Tsimberidou, F. Janku, D.D. Karp, F. Meric-Bernstam, A. Naing
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3088980765